A case of refractory multiple myeloma
Journal: International Journal of Basic & Clinical Pharmacology (Vol.1, No. 1)Publication Date: 2012-08-01
Authors : Ritesh Vekariya Vishal Satadiya Manish Bavaliya Shyam Shah;
Page : 41-42
Keywords : M band; Pathologic fracture; Plasma cell cancer;
Abstract
Multiple myeloma is a plasma cell cancer in which antibody-producing plasma cells grow in an uncontrolled and invasive way. The known incidence of multiple myeloma in India ranges from 0.5 to 1.2 per 100,000 & is a rare in India. It usually occurs in persons older than 55 years and the ratio of men: women is 3:2. Multiple myeloma affects the bones, immune system, kidneys and red blood cell count. We report a case of refractory multiple myeloma.
Other Latest Articles
- Grade 4 oral mucositis and prolonged pancytopenia with high dose intravenous methotrexate in a patient of philadelphia positive acute lymphoblastic leukemia
- A study to evaluate the clinical outcome of drug-eluting vs. bare-metal stents for acute coronary syndrome patients during commercial use in real setting
- Current scenario of rational usage of various drugs in indoor patients
- To study the antihyperglycaemic and lipid lowering effect of garlic as an adjunct to metformin in patients of type 2 diabetes mellitus with obesity
- Approval of antineoplastic agents in India: comparison with the US and EU regions
Last modified: 2012-09-02 00:07:59